Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD



Rating:

Share or cite this content

Citations should be made in the following way:
C. Amado Diago (Santander (Cantabria), Spain), M. García-Unzueta (Santander (Cantabria), Spain), J. Agüero Calvo (Santander (Cantabria), Spain), P. Martín Audera (Santander (Cantabria), Spain), S. Tello Mena (Santander (Cantabria), Spain), S. Izquierdo Cuervo (Santander (Cantabria), Spain), G. Andretta Juarez (Santander (Cantabria), Spain), J. Osorio Chavez (Santander (Cantabria), Spain), M. Cristeto Porras (Santander (Cantabria), Spain), L. Gonzalez Ramos (Santander (Cantabria), Spain), N. Borja Vargas (Santander (Cantabria), Spain), A. Guerra (Santander (Cantabria), Spain), M. Ruiz De Infante Pérez (Santander (Cantabria), Spain), A. Berja (Santander (Cantabria), Spain). Parathyroid hormone: a neglected biomarker of exacerbations and hospitalizations in patients with COPD and hypovitaminosis D.. 3830

Member's Comments

No comment yet.

Related content which might interest you: Vitamin D, exacerbations and hospitalizations in COPD patients Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Serum periostin in patients hospitalized for COPD exacerbations Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Vitamin D status in COPD patients admitted for exacerbation Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 Is vitamin D deficiency a risk factor for COPD exacerbations? Source: Annual Congress 2013 –Environment and lifestyle: associations with respiratory disease Year: 2013 Sex hormones imbalance in patients with acute exacerbation of COPD (AECOPD) Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Vitamin D deficiency and COPD exacerbations: Effect of vitamin D supplementation Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Cardiovascular medications and mortality in patients hospitalised with acute exacerbations of COPD Source: Annual Congress 2013 –COPD biomarkers Year: 2013 BNP level in patients with COPD exacerbations Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Serum vitamin C level in patients with acute pneumonia and in COPD patients before and after therapy Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006 Vitamin-D deficiency & anaemia in patients with acute exacerbations of COPD (AECOPD); morbidity & mortality. Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD Source: Annual Congress 2012 - COPD: risk factors, biomarkers and diagnosis Year: 2012 Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 The impact of bronchiectasis on outcomes in a large cohort of patients hospitalised with exacerbations of COPD Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 Does serum uric acid levels predict in-hospital mortality in severe COPD exacerbations? Source: International Congress 2015 – COPD: interesting notes Year: 2015 Does vitamin D deficiency worsen the hospital outcome in patients with acute exacerbation COPD? Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD Year: 2018 One year vitamin D and parathyroid hormone influence in patients with OSAS and CPAP treatment Source: International Congress 2018 – Treatments that can serve as an alternative to positive airway pressure (PAP) Year: 2018 The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Eosinophilia as marker of outcome in hospitalised patients with AECOPD Source: Annual Congress 2013 –COPD and infections Year: 2013 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014